BMRN — BIOMARIN PHARMACEUTICAL INC

Ownership history in Quantbot Technologies LP  ·  26 quarters on record

This page tracks every 13F SEC filing in which Quantbot Technologies LP reported a position in BIOMARIN PHARMACEUTICAL INC (BMRN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.38% (2015 Q3)
Avg. % of fund
0.06%
First filed
2013 Q4
Last filed
2025 Q3
Quarters held
26
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 9,082 +8,412 +1255.5% 0.01% $492K $54.16
2025 Q2 REDUCED 670 -7,374 -91.7% 0.00% $37K $54.97
2025 Q1 ADDED 8,044 +5,533 +220.4% 0.02% $569K $70.69
2024 Q4 ADDED 2,511 +84 +3.5% 0.01% $165K $65.73
22 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    BMRN price (monthly, adj. close)

Other funds also holding BMRN

As of 2025 Q4 — sorted by position size

Krensavage Asset Management, LLC 3Y 7Y 11.02% BOONE CAPITAL MANAGEMENT LLC 3Y 7.68% Palo Alto Investors LP 3Y 7Y 6.17% Vestal Point Capital, LP 6.06% Eagle Health Investments LP 3Y 4.79% Novo Holdings A/S 3Y 7Y 3.05% Soleus Capital Management, L.P. 3Y 2.89% SECTOR GAMMA AS 3Y 7Y 2.69% Deep Track Capital, LP 3Y 2.44% Sio Capital Management, LLC 3Y 7Y 2.18%
← Back to Quantbot Technologies LP Holdings